Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

NCT01986712

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Moffit Cancer Center Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • St Luke's University Hospital and Health Network Bethlehem, Pennsylvania, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Completed

Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)

NCT03665597

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Orange Health Services ( Site 0004) Orange, New South Wales, Australia
  • Calvary Mater Newcastle ( Site 0006) Waratah, New South Wales, Australia
  • Cairns and Hinterland Hospital and Health Service ( Site 0001) Cairns, Queensland, Australia
  • Royal Adelaide Hospital ( Site 0002) Adelaide, South Australia, Australia
View all 15 locations
View Trial Details
Completed

An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia

NCT04146324

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution Garran, Australian Capital Territory, Australia
  • Local Institution Birtinya, Queensland, Australia
  • Local Institution Cairns, Queensland, Australia
  • Local Institution Greenslopes, Queensland, Australia
View Trial Details
Completed

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

NCT03504488

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

NCT04068181

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Sansum Clinic Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center Newark, Delaware, United States
  • University of Florida Health Cancer Center at Orlando Health Orlando, Florida, United States
  • University of Louisville James Graham Brown Cancer Center Louisville, Kentucky, United States
View all 46 locations
View Trial Details

Related conditions